Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest

Antimicrob Agents Chemother. 2003 Apr;47(4):1403-6. doi: 10.1128/AAC.47.4.1403-1406.2003.

Abstract

The in vitro activities of ABT-773 were evaluated against 15 Listeria monocytogenes strains and 196 coryneform bacteria isolated from clinical samples. One hundred percent of the L. monocytogenes strains were inhibited by </=0.015 micro g of ABT-773/ml. MICs of ABT-773 ( micro g/ml) at which 50% of the isolates tested were inhibited (MIC(50)s) and MIC(90)s for other organisms were 0.125 and 0.5 (Corynebacterium amycolatum), 1 and >32 (Corynebacterium jeikeium), 0.03 and >32 (Corynebacterium minutissimum), >32 and >32 (Corynebacterium pseudodiphtheriticum and Corynebacterium urealyticum), 0.125 and >32 (Corynebacterium striatum), and 0.03 and 0.5 (Rhodococcus equi), respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Clindamycin
  • Corynebacterium / drug effects*
  • Erythromycin / analogs & derivatives*
  • Erythromycin / pharmacology*
  • Humans
  • Ketolides*
  • Listeria monocytogenes / drug effects*
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Ketolides
  • Clindamycin
  • Erythromycin
  • cethromycin